Telix Pharmaceuticals Ltd's ROA from the fourth quarter of 2025 to the fourth quarter of 2024 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Telix Pharmaceuticals Ltd's ROA in the fourth quarter of 2025?
Telix Pharmaceuticals Ltd recorded a cumulative net loss of $-7 million during 12 months ending in the fourth quarter of 2025, resulting in a negative return on assets (ROA) of -0.66%.

However, within the Healthcare sector 238 other companies had a higher return on assets. While the total ranking for ROA unchanged, relative to the third quarter of 2025 at no. .

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Dec 31 2025) IV. Quarter	0 III. Quarter	0 II. Quarter	0 I. Quarter	(Dec 31 2024) IV. Quarter
Y / Y Total Assets Change	-9.67 %	-27.01 %	-27.01 %	-27.01 %	506.7 %
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	-7	50	50	50	50
Return On Assets (TTM)	-0.66 %	4.53 %	4.16 %	3.85 %	3.59 %
TLX's Total Ranking	#	#	#	#	#
Total Assets (TTM) in million	1,164	1,041	1,041	1,041	1,289
Seq. Total Assets Change	11.8 %	0 %	0 %	-19.21 %	-9.66 %
Seq. Net Income Change	-	-	-	-	-

TLX's 5 Years Annual ROA >> Back to TLX Management Effectiveness >> Compare TLX ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 81
Sector	# 239
Overall	# 3090

Return On Assets Statistics
High	Average	Low
-0.61 %	-0.61 %	-0.61 %
(Dec 31 2025)

Financial Statements
Telix Pharmaceuticals Ltd's Assets	$ 1,164 million	TLX's Balance sheet
Telix Pharmaceuticals Ltd's Income	$ -7 million	Quarterly TLX's Income Statement
TLX's Income by Division		See TLX's Income by Division

Annual Return On Assets	(Dec 31 2025) FY 2025	(Dec 31 2024) FY 2024	FY	FY	FY
Y / Y Total Assets Change	43.54 %	-	-	-	-
Total Assets in million	1,841	1,283	0	0	0
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	-7	34	0	0	0
Annual Return On Assets	-0.39 %	2.63 %	-	-	-

TLX's 5 Years Annual ROA >> Back to TLX Management Effectiveness >> Compare TLX ROA to its Competitors

More Return On Assets Ratios
TLX's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
TLX's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for TLX's Competitors
Subscribers only: Roa for Telix Pharmaceuticals Ltd's Suppliers
Subscribers only: Return On Assets for TLX's Customers

You may also want to know
TLX's Roi	TLX's Inventory Turnover Ratio	TLX's Growth Rates	TLX's Dividend Comparisons
	TLX's Profitability Ratios	TLX's Asset Turnover Ratio	TLX's Dividend Growth
TLX's Roe	TLX's Valuation Ratios	TLX's Financial Strength Ratios	TLX's Dividend Payout Ratio

Companies with similar Return On Assets at Dec 31 2025, within Healthcare Sector

ROA

Date modified: 2026-07-07T14:04:47+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.